Makers Laboratories

Makers Laboratories Quick Ratio

The Quick Ratio (Acid Test) of Makers Laboratories (506919.BO) as of Oct 21, 2026 is 0.43. In the previous year, Quick Ratio (Acid Test) was 0.38 — a change of 12.68% (higher).

Quick Ratio

0.43

YoY

12.68%

Last updated:

Quick Ratio (Acid Test) of Makers Laboratories is 2026 0.43 . Quick Ratio (Acid Test) of Makers Laboratories was 2025 0.38 . It decreases by 12.68% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Makers Laboratories Stock analysis

What does Makers Laboratories do? Makers Laboratories Ltd. generates revenue through the manufacturing and marketing of pharmaceutical products across various therapeutic segments. The company's product portfolio includes formulation brands such as Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (anti-cough range), and Exylin (Amoxycillin range). These brands target general health needs and are distributed through the Inspira retail packs division, which covers categories like acid regulatory, anthelmintics, anti-allergics, and anti-hypertensives. The Experia bulk packs division supplies bulk pharmaceutical products including amoxycillin 250 mg capsules and chloroquine phosphate 250 mg tablets to healthcare providers and pharmacies. The company's primary customers are healthcare providers and pharmacies that purchase its formulation brands and bulk packs for resale or direct patient use. The Inspira retail packs division serves retail consumers seeking over-the-counter medications for common ailments, while the Experia bulk packs division caters to institutional buyers needing bulk quantities for distribution. Makers Laboratories Ltd. focuses on the pharmaceuticals segment, offering products that address diverse health conditions through its established brand portfolio. Revenue streams are derived from both retail and bulk sales, with formulation brands driving consumer-facing sales and bulk packs supporting institutional distribution. The company's product range spans multiple therapeutic areas, ensuring consistent demand across different healthcare segments. By maintaining a diverse portfolio of branded and bulk pharmaceutical products, Makers Laboratories Ltd. effectively targets both end consumers and healthcare institutions within the Indian pharmaceutical market. Makers Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Makers Laboratories stock

Quick Ratio (Acid Test) of Makers Laboratories is 0.43 in 2026.

Quick Ratio (Acid Test) of Makers Laboratories changed from 0.38 to 0.43, representing a 12.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Makers Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Makers Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Makers Laboratories

All Key Metrics — Makers Laboratories